Neoadjuvant endocrine therapy with sequential palbociclib and chemotherapy based on Ki67 status in stage II-III breast cancer: An open-label, phase II study
- DOI
- 10.1016/j.breast.2025.104672
- Published
- 2026-02
- Container
- The Breast
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.breast.2025.104672,
title = {Neoadjuvant endocrine therapy with sequential palbociclib and chemotherapy based on Ki67 status in stage II-III breast cancer: An open-label, phase II study},
author = {Christina Engebrethsen and Synnøve Yndestad and Mari E. Rasmussen and Emiel A.M. Janssen and Bjørnar Gilje and Egil S. Blix and Helge Espelid and Steinar Lundgren and Jürgen Geisler and Laura Minsaas and Reidun Lillestøl and Hildegunn S. Aase and Turid Aas and Per E. Lønning and Hans P. Eikesdal and Stian Knappskog},
year = {2026},
journal = {The Breast},
doi = {10.1016/j.breast.2025.104672},
url = {https://doi.org/10.1016/j.breast.2025.104672}
}RIS
TY - JOUR TI - Neoadjuvant endocrine therapy with sequential palbociclib and chemotherapy based on Ki67 status in stage II-III breast cancer: An open-label, phase II study AU - Christina Engebrethsen AU - Synnøve Yndestad AU - Mari E. Rasmussen AU - Emiel A.M. Janssen AU - Bjørnar Gilje AU - Egil S. Blix AU - Helge Espelid AU - Steinar Lundgren AU - Jürgen Geisler AU - Laura Minsaas AU - Reidun Lillestøl AU - Hildegunn S. Aase AU - Turid Aas AU - Per E. Lønning AU - Hans P. Eikesdal AU - Stian Knappskog PY - 2026 JO - The Breast DO - 10.1016/j.breast.2025.104672 UR - https://doi.org/10.1016/j.breast.2025.104672 ER -
APA
Engebrethsen, C., Yndestad, S., Rasmussen, M. E., Janssen, E. A., Gilje, B., Blix, E. S., Espelid, H., Lundgren, S., Geisler, J., Minsaas, L., Lillestøl, R., Aase, H. S., Aas, T., Lønning, P. E., Eikesdal, H. P., & Knappskog, S. (2026). Neoadjuvant endocrine therapy with sequential palbociclib and chemotherapy based on Ki67 status in stage II-III breast cancer: An open-label, phase II study. The Breast. https://doi.org/10.1016/j.breast.2025.104672
Source records
- crossref · retrieved 2026-09-26T13:13:28.217Z